Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan1,2,3,4, Johannes Betge1,2,3,5, Nadine Schulte1,3
1Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Digestive system cancers are a leading cause of death. This review covers their causes, molecular features, and treatments, including chemotherapy, targeted therapy, and immunotherapy, highlighting future strategies like CAR-T cell therapy.
Area of Science:
- Gastroenterology
- Oncology
- Genomics
Background:
- Digestive system cancers cause significant global mortality.
- These cancers exhibit complex and heterogeneous etiologies and molecular profiles.
Purpose of the Study:
- To provide an overview of the etiology, molecular pathology, and current management of six major digestive cancers.
- To discuss recent therapeutic advancements and future strategies for digestive cancers.
Main Methods:
- Literature review of genomic and functional studies.
- Comprehensive description of current stage-dependent pharmacological management.
- Overview of recent therapeutic advancements and research progress.
Main Results:
- Genomic studies have revealed key drivers of tumor progression and immune system interactions.
- Current treatments include chemotherapy, targeted therapy, and immunotherapy.
- Novel insights into tumor heterogeneity and immune evasion are improving therapy resistance understanding.
Conclusions:
- Understanding digestive cancer biology is crucial for developing effective treatments.
- Future strategies include CAR-T cell therapy, antibody-drug conjugates, and targeted therapies.
- Personalized medicine approaches are reshaping the therapeutic landscape.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Tumor Immunotherapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

